13D Filing: Starboard Value LP and Depomed Inc (NASDAQ:DEPO)

Page 19 of 25

Page 19 of 25 – SEC Filing

C.
Starboard C LP
 
(a)
As of the close of business on March 29, 2017, Starboard C LP beneficially owned 277,452 Shares.
Percentage: Less than 1%
 
(b)
1. Sole power to vote or direct vote:  277,452
 
2. Shared power to vote or direct vote: 0
 
3. Sole power to dispose or direct the disposition:  277,452
 
4. Shared power to dispose or direct the disposition: 0
 
(c)
The transactions in the Shares by Starboard C LP during the past sixty days are set forth in Schedule B and are incorporated herein by reference.
D.
Starboard R LP
 
(a)
Starboard R LP, as the general partner of Starboard C LP, may be deemed the beneficial owner of the 277,452 shares owned by Starboard C LP.
Percentage: Less than 1%
 
(b)
1. Sole power to vote or direct vote:  277,452
 
2. Shared power to vote or direct vote: 0
 
3. Sole power to dispose or direct the disposition:  277,452
 
4. Shared power to dispose or direct the disposition: 0
 
(c)
Starboard R LP has not entered into any transactions in the Shares during the past sixty days.  The transactions in the Shares on behalf of Starboard C LP during the past sixty days are set forth in Schedule B and are incorporated herein by reference.
E.
Starboard R GP
 
(a)
Starboard R GP, as the general partner of Starboard R LP, may be deemed the beneficial owner of the 277,452 shares owned by Starboard C LP.
Percentage: Less than 1%
 
(b)
1. Sole power to vote or direct vote:  277,452
 
2. Shared power to vote or direct vote: 0
 
3. Sole power to dispose or direct the disposition:  277,452
 
4. Shared power to dispose or direct the disposition: 0
 
(c)
Starboard R GP has not entered into any transactions in the Shares during the past sixty days. The transactions in the Shares on behalf of Starboard C LP during the past sixty days are set forth in Schedule B and are incorporated herein by reference.

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

Page 19 of 25